Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.27K % +14%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 17.8 % -2.95%
Return On Equity -39.1 % -49.2%
Return On Assets -33.2 % -49.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.3M shares +9.99%
Common Stock, Shares, Outstanding 74.3M shares +10%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 74K USD +10.4%
Weighted Average Number of Shares Outstanding, Basic 74.3M shares +5.19%
Weighted Average Number of Shares Outstanding, Diluted 74.3M shares +5.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 64.2M USD +79.1%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 31.5M USD +35.3%
Operating Income (Loss) -119M USD -106%
Nonoperating Income (Expense) 10.3M USD +32.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -108M USD -118%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -106M USD -65.9%
Earnings Per Share, Basic -1 USD/shares +8.08%
Earnings Per Share, Diluted -1 USD/shares +8.08%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.8M USD -88.2%
Cash, Cash Equivalents, and Short-term Investments 174M USD -35%
Accounts Receivable, after Allowance for Credit Loss, Current 179K USD -17.5%
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 81K USD +80%
Assets, Current 179M USD -33.9%
Property, Plant and Equipment, Net 64.4M USD +46.9%
Operating Lease, Right-of-Use Asset 1.54M USD -36.9%
Intangible Assets, Net (Excluding Goodwill) 279K USD -21.2%
Goodwill 0 USD -100%
Other Assets, Noncurrent 438K USD -36.9%
Assets 295M USD -24.6%
Employee-related Liabilities, Current 6.71M USD +68.8%
Liabilities, Current 20.6M USD -26.7%
Deferred Income Tax Liabilities, Net 2.5M USD -45.7%
Operating Lease, Liability, Noncurrent 971K USD -42.1%
Other Liabilities, Noncurrent 342K USD +936%
Liabilities 52.6M USD -16.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 114K USD
Retained Earnings (Accumulated Deficit) -297M USD -55.2%
Stockholders' Equity Attributable to Parent 242M USD -26.3%
Liabilities and Equity 295M USD -24.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.6M USD -256%
Net Cash Provided by (Used in) Financing Activities 9.97M USD -94%
Net Cash Provided by (Used in) Investing Activities -5.57M USD +88.2%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 74.3M shares +10%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.2M USD -113%
Deferred Tax Assets, Valuation Allowance 41.8M USD +39.6%
Deferred Tax Assets, Gross 50.8M USD +30.9%
Operating Lease, Liability 1.68M USD -35.1%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 4.66M USD -48.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -106M USD -71%
Lessee, Operating Lease, Liability, to be Paid 1.86M USD -36.6%
Property, Plant and Equipment, Gross 69.5M USD +51%
Operating Lease, Liability, Current 704K USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 493K USD -23.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 647K USD -41.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -2.1M USD +20.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 188K USD -47.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 443K USD -10.1%
Deferred Tax Assets, Operating Loss Carryforwards 35.3M USD +31.9%
Preferred Stock, Shares Authorized 7M shares 0%
Unrecognized Tax Benefits 526K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 443K USD +92.6%
Deferred Tax Assets, Net of Valuation Allowance 9M USD +1.49%
Share-based Payment Arrangement, Expense 8.72M USD +126%
Interest Expense 84 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%